CellBion Co., Ltd. (KOSDAQ:308430)

CellBion Statistics

Total Valuation

CellBion has a market cap or net worth of KRW 298.97 billion. The enterprise value is 277.85 billion.

Market Cap	298.97B
Enterprise Value	277.85B

Important Dates

The next estimated earnings date is Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

CellBion has 12.83 million shares outstanding.

Current Share Class	12.83M
Shares Outstanding	12.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+31.93%
Owned by Insiders (%)	36.41%
Owned by Institutions (%)	3.59%
Float	8.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	140.37
PB Ratio	12.07
P/TBV Ratio	12.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-36.78
EV / Sales	130.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-42.69

Financial Position

The company has a current ratio of 17.31, with a Debt / Equity ratio of 0.22.

Current Ratio	17.31
Quick Ratio	17.10
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.84
Interest Coverage	-86.92

Financial Efficiency

Return on equity (ROE) is -54.63% and return on invested capital (ROIC) is -27.65%.

Return on Equity (ROE)	-54.63%
Return on Assets (ROA)	-23.70%
Return on Invested Capital (ROIC)	-27.65%
Return on Capital Employed (ROCE)	-24.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.10
Inventory Turnover	5.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +109.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+109.53%
50-Day Moving Average	20,620.20
200-Day Moving Average	20,742.95
Relative Strength Index (RSI)	56.82
Average Volume (20 Days)	270,594

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellBion had revenue of KRW 2.13 billion and -7.55 billion in losses. Loss per share was -589.39.

Revenue	2.13B
Gross Profit	70.73M
Operating Income	-7.92B
Pretax Income	-7.55B
Net Income	-7.55B
EBITDA	-7.26B
EBIT	-7.92B
Loss Per Share	-589.39

Balance Sheet

The company has 26.60 billion in cash and 5.48 billion in debt, giving a net cash position of 21.12 billion or 1,645.89 per share.

Cash & Cash Equivalents	26.60B
Total Debt	5.48B
Net Cash	21.12B
Net Cash Per Share	1,645.89
Equity (Book Value)	24.78B
Book Value Per Share	1,932.91
Working Capital	26.02B

Cash Flow

In the last 12 months, operating cash flow was -5.88 billion and capital expenditures -626.78 million, giving a free cash flow of -6.51 billion.

Operating Cash Flow	-5.88B
Capital Expenditures	-626.78M
Free Cash Flow	-6.51B
FCF Per Share	-507.24

Margins

Gross Margin	3.32%
Operating Margin	-371.79%
Pretax Margin	-354.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CellBion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.53%
FCF Yield	-2.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CellBion has an Altman Z-Score of 14.62 and a Piotroski F-Score of 3.

Altman Z-Score	14.62
Piotroski F-Score	3